By No Extraordinary Means
نویسندگان
چکیده
منابع مشابه
Debate: extraordinary means and the sanctity of life.
Ms Kuhse argues against the doctrine of 'the sanctity of life', against the application of acts and omissions doctrine in medical practice, and against the common assumption that there is a crucial moral difference between intentionally discontinuing ordinary medical treatment and intentionally discontinuing extra-ordinary medical treatment. Intentional acts or omissions which shorten life are ...
متن کاملIn Haliotis, NO means YES
Settlement and metamorphosis of marine invertebrate larvae is an ecological process of profound importance to the structure of benthic marine communities. Yet, metamorphosis is also a developmental process and our understanding of the mechanisms that regulate it remains relatively poor. Over the last 15 years, a nitric oxide (NO) based signaling system has emerged as the most phylogenetically w...
متن کاملNo NO means yes to sickle red cell adhesion.
In fact, patients with these conditions are particularly prone to developing refractoriness to platelet transfusions, and treatment of bleeding in this situation represents a major clinical problem. The data presented by Colucci et al provide a rationale for hoping that DDAVP can be effective in these emergencies as well as in preparation of patients for surgery or invasive procedures. Much wor...
متن کاملExtraordinary claims require extraordinary evidence.
At the beginning of 2003, the Journal of Health Economics published a paper of great importance in public policy by DiMasi, Hansen, and Grabowski (referred to hereafter as “DHG 2003”). The paper is based primarily on confidential, proprietary data supplied by pharmaceutical companies to the Tufts Center for the Study of Drug Development, a research center that receives significant unrestricted ...
متن کاملExtraordinary claims require extraordinary evidence
We thank Light and Warburton (2005) [hereafter LW] for providing a context for us to further discuss and clarify our studies on the cost of new drug development (DiMasi et al., 2003 [hereafter DHG]; DiMasi et al., 1991b [hereafter DHGL]; Hansen, 1979). We disagree, however, with their analyses, comparators, and conclusions. Although LW suggest, through the invocation of selected reported cost f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Medical Ethics
سال: 1988
ISSN: 0306-6800
DOI: 10.1136/jme.14.1.51